A new Cochrane review confirms that antidepressants effectively reduce symptoms of generalized anxiety disorder (GAD) under ...

Teens and young adults with anxiety, ADHD, or sleep disorders were more likely to have a diagnosis of addiction to sedatives ...

Weill Cornell Medicine investigators have identified in a preclinical model a specific brain circuit whose inhibition appears to reduce anxiety without side effects.

What if the key to reducing stress and anxiety lies in how you view your challenges? Based on cognitive reframing practices, ...

We can begin to control anxiety when we understand its genetic survival value, recognize its distortions, and learn how to ...

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

If you have insomnia or periodic restless nights, you know what it's like to lie awake in bed exhausted when your mind won't ...

CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult ...